METASTATIC LESION OF THE SPINE DUE TO RENAL CELL CARCINOMA: OUTCOMES AND SURVIVAL AFTER TUMOR RESECTION
https://doi.org/10.14531/ss2017.4.110-116
Abstract
Objective. To evaluate the impact of surgical intervention and targeted therapy on the results of treatment and survival of patients with metastases of renal cell carcinoma to the spine.
Material and Methods. Retrospective analysis of 100 patients (76 men, 24 women, mean age 58.4 years) with renal cell carcinoma metastases to the spine was carried out. Metastasectomy (en block resection) was performed in 39 patients, palliative decompression and stabilization — in 61. Twenty six patients received adjuvant targeted therapy (7 with metastasectomy, 19 with palliative decompression). The pain syndrome (VAS), neurological status (Frankel scale), and survival time (from the moment of surgery till the lethal outcome or the last follow-up examination) were assessed. The Kaplan – Meier survival analysis and Log-rank test were performed. A p-value < 0.05 was considered significant.
Results. All patients demonstrated restoration of neurologic function and reduction of pain syndrome. There was no significant difference in survival time in patients with metastasectomy and palliative decompression (p = 0.47). Statistically significant survival benefit was observed in patients who underwent targeted therapy (p = 0.0019).
Conclusion. Targeted therapy increases survival time in patients with renal cell carcinoma metastases to the spine. Metastasectomy is advisable with additional targeted therapy.
About the Authors
Nikita S. ZaborowskyRussian Federation
MD fellow, Department of Neuroorthopaedics and Bone Oncology, Vreden Russian Research Institute of Traumatology and Orthopаedics
Akademika Baikova str., 8, St. Petersburg, 195427, Russia
Stanislav V. Kostritckii
Russian Federation
oncologist at Oncourology Department, Moscow Oncology Hospital No. 62
Dmitry A. Ptashnikov
Russian Federation
DMSc, Prof., head of the Department of Neuroorthopaedics and Bone Oncology, Vreden Russian Research Institute of Traumatology and Orthopаedics, St. Petersburg; Mechnikov North-West State Medical University
Valeriy I. Shirokorad
Russian Federation
DMSc, head of Oncourology Department, Moscow Oncology Hospital No. 62
References
1. Валиев А.К., Мусаев Э.Р., Сушенцов Е.А., Борзов К.А., Алиев М.Д. Опухоли позвоночника и перспективы их лечения на современном этапе развития вертебрологии // Травматология и ортопедия России. 2010. № 2(56). С. 126–128. [Valiev AK, Musaev ER, Sushentsov EA, Borzov KA, Aliev MD. Spinal tumors and its treatment perspectives in our days. Traumatology and Orthopedics of Russia. 2010;(2):126–128. In Russian].
2. Михайлов Д.А., Пташников Д.А., Усиков В.Д., Магомедов Ш.Ш., Масевнин С.В., Смекаленков О.А., Заборовский Н.С., Засульский Ф.Ю., Григорьев П.В., Микайлов И.М. 15-летний опыт реконструктивно-стабилизирующих операций в комплексном лечении опухолей позвоночника // Cаркомы костей, мягких тканей и опухоли кожи. 2014. № 2. С. 69. [Mikhaylov DA, Ptashnikov DA, Usikov VD, Magomedov ShSh, Masevnin SV, Smekalenkov OA, Zaborovskii NS, Zasul’skiy FYU, Grigor’yev PV, Mikaylov IM. A 15-year experience of reconstructive and stabilizing surgery in the complex management of spinal tumors. Sarkomy kostey, myagkikh tkaney i opukholi kozhi. 2014;23(2):69. In Russian].
3. Состояние онкологической помощи населению России в 2015 году / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2016. [A State of Cancer Care for Population of Russia in 2015. Kaprin AD, Starinskiy VV, Petrova GV, eds. Moscow, 2016. In Russian].
4. Тихилов Р.М., Карагодин Д.Ф., Пташников Д.А., Усиков В.Д., Магомедов Ш.Ш. Остеосинтез позвоночника при патологических переломах на фоне распространенного метастатического поражения в сочетании с лучевой и химиотерапией // Травматология и ортопедия России. 2010. № 1(55). С. 14–20. [Tikhilov RM, Karagodin DF, Ptashnikov DA, Usikov VD, Magomedov ShSh. Osteosynthesis of the spine in pathological fractures against the background of extensive metastatic spread in combination with radiation and chemotherapy. Traumatology and Orthopedics of Russia. 2010;(1)14–20. In Russian]. DOI: http://dx.doi.org/10.21823/2311-2905-2010-0-1-14-20.
5. Усиков В.Д., Пташников Д.А., Магомедов Ш.Ш. Корпор- и спондилэктомия в системе хирургического лечения опухолей позвоночника // Травматология и ортопедия России. 2010. Т. 56. № 2. С. 140–142. [Usikov VD, Ptashnikov DA, Magomedov SS. Corpor- and spondylectomy in system of surgical treatment of vertebral tumors. Traumatology and Orthopedics of Russia. 2010;(2):140–142. In Russian].
6. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–6249s. DOI: 10.1158/1078-0432.CCR-06-0931.
7. Furstenberg CH, Wiedenhofer B, Gerner HJ, Putz C. The effect of early surgical treatment on recovery in patients with metastatic compression of the spinal cord. J Bone Joint Surg Br. 2009;91:240–244. DOI: 10.1302/0301-620X.91B2.20894.
8. Grant R, Papadopoulos SM, Greenberg HS. Metastatic epidural spinal cord compression. Neurologic Clinics. 1991;9:825–841.
9. Jackson RJ, Loh SC, Gokaslan ZL. Metastatic renal cell carcinoma of the spine: surgical treatment and results. J Neurosurg. 2001;94(1 Suppl):18–24.
10. Jung ST, Ghert MA, Harrelson JM, Scully SP. Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res. 2003;(409):223–231.
11. Kato S, Murakami H, Demura S, Nambu K, Fujimaki Y, Yoshioka K, Kawahara N, Tomita K, Tsuchiya H. Spinal metastasectomy of renal cell carcinoma: A 16 year single center experience with a minimum 3 year follow up. J Surg Oncol. 2016;113:587–592. DOI: 10.1002/jso.24186.
12. Kim HJ, Buchowski JM, Moussallem CD, Rose PS. Modern techniques in the treatment of patients with metastatic spine disease. J Bone Joint Surg Am. 2012;94:943–951. DOI: 10.2106/JBJS.L00192.
13. Kume H, Kakutani S, Yamada Y, Shinohara M, Tominaga T, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Homma Y. Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? J Urol. 2011;185:1611–1614. DOI: 10.1016/j.juro.2010.12.037.
14. Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol. 2006;24:16–24. DOI: 10.1200/JCO.2005.02.2574.
15. Prabhu VC, Bilsky MH, Jambhekar K, Panageas KS, Boland PJ, Lis E, Heier L, Nelson PK. Results of preoperative embolization for metastatic spinal neoplasms. J Neurosurg Spine. 2003;98:156–164. DOI: 10.3171/spi.2003.98.2.0156.
16. Quraishi NA, Purushothamdas S, Manoharan SR, Arealis G, Lenthall R, Grevitt MP. Outcome of embolised vascular metastatic renal cell tumours causing spinal cord compression. Eur Spine J. 2013;22 Suppl 1:S27–S32. DOI: 10.1007/s00586-012-2648-6.
17. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2013. URL: https://www.R-project.org/.
18. Sciubba DM, Gokaslan ZL. Are patients satisfied after surgery for metastatic spine disease? Spine J. 2010;10:63–65. DOI: 10.1016/j.spinee.2009.10.004.
19. Sundaresan N, Boriani S, Okuno S. State of the art management in spine oncology: a worldwide perspective on its evolution, current state, and future. Spine. 2009;34(22 Suppl):S7–S20. DOI: 10.1097/BRS.0b013e3181bac476.
Review
For citations:
Zaborowsky N.S., Kostritckii S.V., Ptashnikov D.A., Shirokorad V.I. METASTATIC LESION OF THE SPINE DUE TO RENAL CELL CARCINOMA: OUTCOMES AND SURVIVAL AFTER TUMOR RESECTION. Russian Journal of Spine Surgery (Khirurgiya Pozvonochnika). 2017;14(4):110-116. https://doi.org/10.14531/ss2017.4.110-116